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Abstract
Background: Empirical research has revealed a positive relationship between type 2 diabetes mellitus and
depression, but questions remain regarding timing of depression measurement, types of instruments used to
measure depression, and whether “depression” is defined as clinical depression or depressive symptoms. The
present study sought to establish the robustness of the depression-diabetes relationship across depression
definition, severity of depressive symptoms, recent depression, and lifetime depression in a nationally representative
dataset and a large rural dataset.
Methods: The present examination, conducted between 2014 and 2015, used two large secondary datasets: the
National Health and Nutrition Examination Survey (NHANES) from 2007 to 2008 (n = 3072) and the Arthritis, Coping,
and Emotion Study (ACES) from 2002 to 2006 (n = 2300). Depressive symptoms in NHANES were measured using
the Patient Health Questionnaire 9-item survey (PHQ-9). ACES used the Center for Epidemiologic
Studies—Depression Scale (CES-D) to measure depressive symptoms and the Composite International Diagnostic
Interview (CIDI) to measure diagnosable depression. Diabetes was modelled as the dichotomous outcome variable
(presence vs. absence of diabetes). Logistic regression was used for all analyses, most of which were cross-sectional.
Analyses controlled for age, ethnicity, sex, education, and body mass index, and NHANES analyses used sample
weights to account for the complex survey design. Additional analyses using NHANES data focused on the addition
of health behavior variables and inflammation to the model.
Results: NHANES. Every one-point increase in depressive symptoms was associated with a 5% increase in odds of
having diabetes [OR: 1.05 (CI: 1.03, 1.07)]. These findings persisted after controlling for health behaviors and
inflammation. ACES. For every one-point increase in depressive symptom score, odds of having diabetes increased
by 2% [OR: 1.02 (CI: 1.01, 1.03)]. Recent (past 12 months) depression [OR: 1.49, (CI: 1.03, 2.13)] and lifetime
depression [OR: 1.40 (CI: 1.09, 1.81)] were also significantly associated with having diabetes.
Conclusions: This study provides evidence for the robustness of the relationship between depression or depressive
symptoms and diabetes and demonstrates that depression occurring over the lifetime can be associated with
diabetes just as robustly as that which occurs more proximal to the time of study measurement.
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Background
Depression is devastating to productivity, relationships,
and overall well-being and, in the United States (US), re-
mains second only to back pain as a leading cause of dis-
ability [1]. Despite having an estimated lifetime
prevalence of 20% in adults [2], it frequently goes un-
diagnosed and untreated, owing in part to a dramatic
shortage of mental health care providers [3]. Untreated
depression is associated with greater quantity and sever-
ity of physical and mental health comorbidities [4]. For
instance, depression is frequently comorbid with sleep
problems, [5] anxiety, [6] and cardiovascular disease [7].
Depression is often associated with risky health behav-
iors, such as poor diet, sedentariness, and smoking,
which, in turn, increase risk for chronic diseases like
obesity and diabetes [8].
Diabetes mellitus, a frequent comorbidity, impacts 26
million Americans. Approximately 95% of cases are type
2 [9]. The prevalence of diabetes has increased rapidly,
fueled by a worldwide increase in obesity, population
aging, and longer life expectancies [10]. Altering behav-
ioral risk factors like unhealthy diet and sedentariness
reduces diabetes risk [11, 12]. Innovative prevention ef-
forts are needed, and, therefore, interest in psychosocial
approaches to preventing diabetes has grown in recent
years [13–15]. As one example, peer support programs,
in which trained helpers offer guidance and support for
people at risk for a health condition, have proven invalu-
able in encouraging individuals to follow recommended
health behaviors. Improved health behaviors, in turn, re-
duce risk for diabetes and other chronic diseases [16, 17].
People with depression are more likely to have
diabetes than those in the general population [18]. The
reverse is also true; depression prevalence among indi-
viduals living with diabetes is estimated to range from
9% to 35% [19, 20]. Bidirectional pathways drive this co-
morbidity. Researchers using a decade of data from the
Nurses’ Health Study found a 17% increase in diabetes
risk for individuals with depression and a 29% increase
in depression risk for those with diabetes [21]. Another
study showed a 43% increase in depression risk over six
years for participants with baseline diabetes and a 102%
increase in risk for diabetes among those with depres-
sion at baseline [22].
Knowing whether timing of depression diagnosis
(recent versus at any point over the lifetime) matters in
association with diabetes risk would prove informative
for preventive interventions. The goal of the present
study was therefore to explore the robustness of the
relationship between depressive symptoms and diabetes
status across varied samples, measures, and contexts.
Analyses for this study were based on two distinct
samples: a large, nationally representative sample (the
National Health and Nutrition Examination Survey
[NHANES]) [23] and a population sample addressing
arthritis and other chronic diseases among rural com-
munities in North Carolina (the Arthritis, Coping, and
Emotion Study [ACES]), part of a larger study of osteo-
arthritis in the region known as the Johnston County
Osteoarthritis Project (JoCo OA) [24]. Researchers
hypothesized a robust, positive relationship between
depression and diabetes status.
Methods
Study samples
The present investigation, conducted between 2014 and
2016, was a secondary analysis of data from two inde-
pendent studies: NHANES and ACES. NHANES is a
continuing series of independent studies of chronic dis-
ease risk factors among non-institutionalized civilians in
the United States. Conducted in person, the study draws
data from interviews and laboratory measures. The de-
identified data are freely available from the National
Center for Health Statistics [23]. Because the ACES
study enrolled only individuals 45 years of age and older,
the present NHANES analyses were restricted to adults
in this age range.
ACES data were collected between 2002 and 2006
from a subset of individuals who participated in JoCo
OA, a longitudinal, epidemiological study of knee and
hip osteoarthritis in rural North Carolina (NC) [24].
Using in-person, in-depth interviews, ACES investigators
collected data to identify psychosocial, behavioral, and
disease-related factors that mitigate or exacerbate psy-
chiatric comorbidity with physical illness in older adults.
ACES included self-reported psychosocial data and col-
lected participants’ weight and height. Inclusion criteria
were being Caucasian or African American, living in
Johnston County, being a civilian, and being at least
45 years of age. The first wave of data, collected from
2001 to 2006, was used in the present study.
Measures
Depression
NHANES included the nine item Patient Health Ques-
tionnaire (PHQ-9) [25, 26]. Items assess the frequency
of depressive symptoms as categorized in the fourth edi-
tion of the Diagnostic and Statistical Manual for Mental
Disorders (DSM-IV) (e.g., “little interest or pleasure in
doing things”), and responses are made on the following
scale: not at all (0), several days (1), more than half the
days (2), and nearly every day (3). Responses were
summed to create a score with a possible range of 0 to
27; higher scores indicate higher levels of depressive
symptoms. The PHQ-9 has been validated in individuals
living with diabetes [27].
ACES included the Composite International Diagnos-
tic Interview (CIDI), [28] which can identify probable
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cases of depression that occurred over the lifetime and
over the previous 12 months using an algorithm based
on third edition of the Diagnostic and Statistical Man-
ual for Mental Disorders, Revised (DSM-III-R) criteria.
The study also assessed depressive symptoms using the
Center for Epidemiologic Studies–Depression (CES-D)
scale [29]. The CES-D contains 20 items (e.g., “I was
bothered by things that usually don't bother me”), and
participants rated how often they were true: rarely or
none of the time (0); some or a little of the time (1); oc-
casionally or a moderate amount of time (2); or most or
all of the time (3). The CES-D responses were summed
to create a score of 0 to 60, with higher scores indicating
higher levels of depressive symptoms. Reverse coding
was used where appropriate.
Diabetes
Type 2 diabetes was a dichotomous outcome variable in
both studies. The 2007–2008 NHANES study followed
standards outlined by the Centers for Disease Control and
Prevention (CDC): a respondent was classified as having
diabetes if he or she had a fasting plasma glucose (FPG)
level of at least 126 or a glycated hemoglobin (HbA1c)
level of at least 6.5, or if he or she reported having a doc-
tor’s diagnosis of diabetes [9]. For ACES, diabetes was de-
fined using a dichotomous, self-reported item indicating
that a doctor had “ever told” the respondent that he or
she has diabetes or high blood sugar. Recent studies
examining the veracity of self-reported diabetes status as
compared to health insurance administrative records and
measured diabetes indices revealed very strong correla-
tions between the measures [30, 31].
Covariates
Both studies controlled for sex (female = 1, male = 0);
ethnicity (Caucasians = 0, African Americans = 1,
NHANES Latino = 2, NHANES Other = 3); age; body
mass index (BMI); and education (high school or less = 1,
more than high school education = 0). Income data were
not collected in the ACES study because investigators felt
they were too sensitive.
Statistical analysis
Analyses were conducted using SAS version 9.3 software
(SAS Institute, Cary, NC). Descriptive statistics were
used to examine the distribution of all variables. Univari-
ate analyses of quantitative (continuous) variables pro-
ceeded using PROC MEANS and PROC UNIVARIATE
to determine range, skewness and kurtosis, and statis-
tical mean and standard deviation. PROC FREQ was
used to provide a descriptive examination of each
categorical variable. It was unnecessary to transform any
variable to facilitate inclusion in subsequent multivariate
analyses; all continuous variables met criteria for
normalcy according to these tests. Bivariate analyses
(Wald chi-square tests) were conducted to determine
the degree to which each predictor was related to
diabetes status.
In multivariate analyses, categorical variables with more
than two levels (e.g., “ethnicity” in NHANES) were entered
into the model as ordinal variables. SAS PROC LOGISTIC
(for ACES data) and PROC SURVEYLOGISTIC (for
NHANES data, given the complex survey design) were
used for logistic regression analysis. For the NHANES data,
the logistic regression models were adjusted for the
complex sampling design by using Mobile Examination
Center (MEC) weights. Odds ratios and 95% Wald confi-
dence limits were reported. Multivariate analyses statistically
controlled for age, ethnicity, sex, education level, and body
mass index.
Further analyses were conducted using the NHANES
data, which included health behavior variables associated
with diabetes that were not included in the ACES data-
set, to gain a more robust understanding of the way
health behaviors contributed to the relationship between
depression and diabetes. These analyses allowed for
evaluation of the association of depressive symptoms
with diabetes after controlling for health behavior vari-
ables, which included: smoking (never = 0, former = 1,
current = 2), sedentary behavior (self-reported lack of
any physical activity; active = 0, sedentary = 1), and self-
rated healthiness of diet (poor/fair = 1, good/very good/
excellent = 0). This model also controlled for inflamma-
tion (C-reactive protein from laboratory blood draw,
measured quantitatively).
The Institutional Review Board at the University of
North Carolina at Chapel Hill reviewed the protocol for
the present study and exempted it, as it involved only
secondary analysis of de-identified data. Participants in
each of the constituent studies provided informed
consent at the time of data collection, and each parent
study received approval and oversight from its respective
ethics board.
Results
Sample characteristics
Descriptive statistics for the 3072 NHANES participants
and the 2300 ACES participants are presented in Table 1.
In both datasets, approximately one in five respondents
had diabetes and 12–13% met the scale’s requirements
for significant depressive symptomatology. The lifetime
prevalence or “history” of depression in ACES was nearly
23%, whereas the prevalence of “recent” (12-month)
depression was 8%. The ACES sample was slightly older,
was more likely to be female, and had fewer Caucasians
than the NHANES sample. The NHANES sample had
more than twice as many respondents having pursued
education beyond high school. The mean body mass
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indexes of both samples were comparable at 29 kg/m2.
For the PHQ-9 (NHANES depressive symptoms meas-
ure), the raw Cronbach’s alpha was 0.85 in the present
data, and raw alpha for the CES-D (ACES depressive
symptoms measure) was 0.91 for the present data. Thus,
the items in the scales were cohesive.
Bivariate models
In NHANES, without adjusting for covariates, every 1-
point increase in PHQ-9 score above the mean was asso-
ciated with a 5% increase in odds of having diabetes
[OR: 1.05 (95% CL: 1.03, 1.07)] (Table 2). In general, be-
ing older, being African American or Latino, having a
high school education or less, and high BMI were each
independently associated with increased diabetes risk
over their respective comparison groups.
For the ACES data, before adjusting for covariates, de-
pressive symptoms were independently associated with
diabetes status such that a 1-point increase in CES-D
score was associated with a 2% increase in likelihood of
having diabetes [OR: 1.02 (1.01, 1.03)]. There was a 58%
increase in diabetes risk for recent depression [OR: 1.58
(1.13, 2.20)] and 35% for lifetime depression [OR: 1.35
(1.07, 1.70)]. Being African American, having a high
BMI, and having a high school education or less each in-
creased the odds of diabetes. Age was not significantly
associated with odds of having diabetes [OR: 1.00 (0.99,
1.01)], but it was included in the multivariate model for
its theoretical and clinical importance.
Table 1 Description and comparison of NHANES and ACES samples
Characteristic NHANES (n = 3072) ACES (n = 2300)
Percent with diabetes 19.2% 20.7%
Percent with depression or mean
depressive symptoms score
PHQ-9: 3.2 out of 27, SEa = 0.2 CES-D: 8.1 out of 60, SDb = 9.1
Recent (12 months): 8.1%
Lifetime: 22.9%
Mean age 59.5 years, SE = 0.3 65.1 years, SD = 10.5
Ethnicity African American: 10.0%
Latino: 8.7%
Caucasian: 76.2%
Other: 5.1%
African American: 33.8%
Caucasian: 66.2%
Sex: Female 53.6% 68.1%
Education: High school or less 47.3% 75.0%
Mean body mass index 29.0, SE = 0.2 29.8, SD = 6.8
aSD = Standard Error
bSE = Standard Deviation
Table 2 Odds ratios and confidence intervals indicating bivariate associations with diabetes status
NHANES ACES
n = 3072 n = 2300
Variable name ORa 95% CIb OR 95% CI
Depressive symptoms 1.05 1.03, 1.07 1.02 1.01, 1.03
Depression, recent – – 1.58 1.13, 2.20
Depression, lifetime – – 1.35 1.07, 1.70
Age (in years) 1.03 1.02, 1.04 1.00 0.99, 1.01
Ethnicity (reference: Caucasian)
African American 2.46 1.86, 3.26 1.63 1.32, 2.00
Latino 1.76 1.29, 2.39 – –
Other 1.14 0.56, 2.32 – –
Sex: Female (reference: male) 0.84 0.69, 1.02 1.23 0.99, 1.53
Education (reference: more than high school) 2.02 1.66, 2.46 1.65 1.30, 2.09
Body mass index (in kg/m2) 1.12 1.09, 1.15 1.07 1.06, 1.09
Boldface indicates statistical significance (p < 0.05)
aOR = Odds Ratio
bCI = 95% Wald Confidence Interval
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Multivariate models
NHANES
As shown in Table 3, the relationship between depressive
symptoms and diabetes status seen in the bivariate model
persisted after adjusting for sex, ethnicity, age, education,
and BMI [OR: 1.05 (1.03, 1.07)]. Because depressive symp-
toms were measured continuously, the odds ratio indi-
cates that the odds of having diabetes increased by 5% for
every 1-point increase in PHQ-9 score above the mean.
Odds ratios were significant for all covariates except the
“other” level of ethnicity, indicating protective effects for
being female, being Caucasian, being younger (closer to
age 40), and having at least some postsecondary educa-
tion. For every year of age over the mean, the odds of
having diabetes increased by 5% [OR: 1.05 (CI: 1.04,
1.06)]. The odds of diabetes were 2.4 times as high for
African Americans and 1.8 times as high for Latinos as for
Caucasians. The odds of diabetes in women were about
one-third lower than those for men [OR: 0.66 (CI: 0.51,
0.85)]. Having a high school diploma or less was associ-
ated with a 68% increase in odds for diabetes compared to
those who have at least some post-secondary education
[OR: 1.68 (CI: 1.29, 2.17)]. Every 1 kg/m2 increase in BMI
over the mean was associated with a 13% higher odds of
having diabetes [OR: 1.13 (CI: 1.10, 1.16)].
NHANES plus behavioral variables and inflammation
The relationship between depressive symptoms and dia-
betes status persisted even after the addition to the
multivariate model of the three health behavior variables
(smoking, diet, and sedentary behavior) and inflamma-
tion. For every 1-point increase in PHQ-9 score over the
mean, odds of diabetes rose by 4% [OR: 1.04 (CI: 1.02,
1.06)] (Table 3). Former smoking, current smoking,
inflammation, and self-reported unhealthy diet were not
significantly associated with diabetes status in the multi-
variate model. Being sedentary, however, was associated
with a 58% increase in odds of having diabetes as com-
pared to having at least some physical activity [OR: 1.58
(CI: 1.23, 2.03)].
Aces
As shown in Table 4, self-reported diabetes was associ-
ated with CES-D depressive symptoms score [OR: 1.02
(CI: 1.01, 1.03)] and CIDI report of recent [OR: 1.49 (CI:
1.03, 2.13)] and lifetime [OR: 1.40 (CI: 1.09, 1.81)] de-
pression after adjusting for covariates. Being older, hav-
ing African American ethnicity, having a high school
diploma or less, and having higher BMI were associated
with increased odds of diabetes, while female gender
was not significant in any model.
Discussion
This study demonstrated a consistent and robust rela-
tionship between depression and diabetes. These find-
ings were substantial and significant across instruments
used to measure depression (PHQ-9, CIDI, CES-D),
timing of depression (recent versus lifetime exposure),
classification of the “depression” variable (diagnosable
depression versus depressive symptomatology), and
Table 3 ORs and CIs for the multivariate and full NHANES models (n = 3072)
Main Model Main model + health behaviors + inflammation
Variable name ORa 95% CIb OR 95% CI
Depressive symptoms (PHQ-9 score) 1.05 1.03, 1.07 1.04 1.02, 1.06
Age (in years) 1.05 1.04, 1.06 1.05 1.04, 1.06
Ethnicity (reference: Caucasian)
African American 2.45 1.85, 3.25 2.51 1.91, 3.30
Latino 1.78 1.32, 2.40 1.77 1.34, 2.33
Other 1.79 0.95, 3.37 1.89 0.96, 3.70
Sex: Female (reference: male) 0.66 0.51, 0.85 0.64 0.49, 0.85
Education (reference: more than high school) 1.68 1.29, 2.17 1.52 1.19, 1.94
Body mass index (in kg/m2) 1.13 1.10, 1.16 1.12 1.09, 1.16
Smoking (reference: Never)
Current – – 0.98 0.71, 1.36
Former – – 1.04 0.67, 1.61
Diet (reference: good/very good/excellent) – – 1.07 0.70, 1.63
Sedentariness (reference: active) – – 1.58 1.23, 2.03
C-reactive protein (in mg/L) – – 0.99 0.91, 1.07
Boldface indicates statistical significance (p < 0.05)
aOR = Odds Ratio
bCI = 95% Wald Confidence Interval
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study context (nationally representative versus represen-
tative of a specific rural county). The relationship be-
tween depression and diabetes persisted after controlling
for the effects of body mass index and demographic
characteristics on diabetes status and, for NHANES,
remained robust even with the addition of three health
behavior variables and a measure of inflammation.
The present findings add to empirical knowledge the
observation that lifetime history of depression is asso-
ciated with increased diabetes risk. Most previous
studies of the relationship between depression and dia-
betes have used measures of depressive symptoms
taken at the time of the baseline interview or within
the previous year [22, 32, 33]. Having any history of
experiencing depression was associated with signifi-
cantly increased odds of having diabetes when com-
pared to those who never had depression. The odds of
diabetes diagnosis were sizeable for all measures of
depression, and they remained robust across depres-
sion diagnosed proximally or over the lifetime and for
both the nationally representative sample and the
smaller rural study sample. Additional research is war-
ranted to gain a better understanding of the relative
importance of depression compared to other variables
in the etiology of diabetes; some mechanisms, such as
inflammation, [34] may impact both diabetes and
depression. The findings here imply mental health, and
specifically depression, should be considered when
designing interventions.
Treatment studies suggest a causal association be-
tween diabetes and depression, although the direction
of causality may be complex. When depression is
treated in people with diagnosed diabetes, hemoglobin
A1c (HbA1c), a biomarker for glucose control, de-
creases moderately [35]. The elevated risk for diabetes
associated with depression remains even when other
recognized diabetes risk factors are considered, includ-
ing risk conferred by some antidepressants [32], poor
diet, [36, 37] family history, [37] inflammation, [33] and
sedentary lifestyle [36, 38].
Limitations
As with many studies of depression and diabetes, this
study uses mostly cross-sectional data, precluding infer-
ences of causality. It remains unclear whether depression
produces diabetes, is produced by it, or co-evolves with
it. However, history of depression could hint at depres-
sion’s contribution to diabetes risk based on a
retrospective-prospective study design [39]. Participants
were asked to reflect retrospectively on symptoms they
have experienced over the course of their lives, and these
reflections were used by the CIDI computerized adaptive
test to judge whether the symptoms were sufficient for a
diagnosis of depression [28]. Then, lifetime depression
status was used as a predictor of diabetes, providing
some evidence for the claim that the two conditions are
causally related.
There are other limitations to the present work.
Researchers were unable to exclude individuals with type
1 diabetes from either analysis. For ACES, diabetes
status was dichotomous and entirely self-reported, and
no data were collected to indicate the type of diabetes a
participant had. Also, it is no longer safe to assume that
all diabetes that occurs during or before adolescence is
Type 1, given the rise of Type 2 diabetes among teen-
agers [9]. However, it is estimated that only 5% of all
diabetes cases are Type 1 [9]. Another limitation is that
both datasets relied heavily on self-reported data for
depression rather than clinical interviews or formal diag-
noses, although the reliability and validity of instruments
used is well-established [25–27, 29]. Self-report data are
vulnerable to recall bias and other threats to validity.
Finally, these analyses did not control for conditions that
are frequently associated with depression and may also
be associated with diabetes, such as anxiety and sleep
disorders [5, 6].
Although generality cannot be proven, the present find-
ings add substantially to previous evidence that the
relationships between depression and diabetes are robust
across methods and populations. The data analyzed were
derived from large, community-based samples. The
Table 4 ORs and CIs for the multivariate model in ACES (n = 2300)
CES-D Recent Depression Lifetime Depression
Variable name ORa 95% CIb OR 95% CI OR 95% CI
Depression indicator 1.02 1.01, 1.03 1.49 1.03, 2.13 1.40 1.09, 1.81
Age (in years) 1.02 1.01, 1.03 1.02 1.01, 1.03 1.02 1.01, 1.03
African American ethnicity (reference: Caucasian) 1.31 1.05, 1.63 1.34 1.08, 1.68 1.38 1.11, 1.73
Sex: Female (reference: male) 1.02 0.81, 1.29 1.04 0.82, 1.30 1.01 0.80, 1.27
Education (reference: more than high school) 1.35 1.05, 1.73 1.40 1.09, 1.79 1.43 1.12, 1.83
Body mass index (in kg/m2) 1.07 1.06, 1.09 1.07 1.06, 1.09 1.07 1.06, 1.09
Boldface indicates statistical significance (p < 0.05)
aOR = Odds Ratio
bCI = 95% Wald Confidence Interval
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NHANES random sample purports to be representative of
the United States population when properly weighted, so
results using these data should be generalizable to individ-
uals outside of those studied directly. The ACES dataset
was a biracial, older-aged sample from a rural North
Carolina county and therefore may be less generalizable
than NHANES. Nevertheless, taken together, the findings
from national and local data are informative.
Conclusions
The strength of the relationship between lifetime experi-
ence of depression and diabetes risk suggests that inter-
ventions designed to lessen the burden of diabetes should
focus on depression that occurs at any time over a per-
son’s lifespan rather than only that which is detected im-
mediately at the time of diabetes diagnosis or treatment.
Much of the ongoing research in this field is biomedical,
yet a multilevel public health model is needed to move
this research forward by considering the myriad factors
that contribute to each health outcome. This wider-lens
model would also allow researchers and clinicians to in-
clude social determinants like education, which in the
present analyses had a strong relationship with diabetes
even after controlling for depression, in interventions.
The results from the present analyses demand the recon-
struction of the current biomedical model to be more in-
clusive of psychosocial factors associated with disease. This
model can then be used to develop interventions that will
treat both body and mind. For example, several random-
ized controlled trials are underway in which researchers
are using cognitive behavioral therapy to relieve depression
among people living with diabetes, with the ultimate goal
of managing their diabetes more effectively [40, 41].
Amidst the burgeoning literature addressing relation-
ships among depression and other mental health indicators
on the one hand, and diabetes and other physical health
conditions on the other, the present findings add evidence
of the robustness of the depression-diabetes connection
across several populations as well as sampling, measure-
ment, and analytic approaches. They also add the novel
finding that a reported history of depressive symptoms is
predictive of later diabetes. In addition to reinforcing the
general interest in these issues, the present findings add
evidence for the importance of depression as an indicator
for both prevention and treatment of diabetes.
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